GLUCOBAY 100 TABLET 100 mg

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

ACARBOSE

Available from:

BAYER (SOUTH EAST ASIA) PTE LTD

ATC code:

A10BF01

Dosage:

100 mg

Pharmaceutical form:

TABLET

Composition:

ACARBOSE 100 mg

Administration route:

ORAL

Prescription type:

Prescription Only

Manufactured by:

Bayer AG

Authorization status:

ACTIVE

Authorization date:

1994-10-01

Patient Information leaflet

Glucobay_PI_SG_CCDS 19_27 Oct 12                     

                                    Page 1 


-GLUCOSIDASE INHIBITOR                      

                             TABLETS 

       PRESCRIPTION USE ONLY 

NAME OF THE MEDICINAL PRODUCT 

Glucobay 50 mg tablets 
Glucobay 100 mg tablets 

QUALITATIVE AND QUANTITATIVE COMPOSITION
: 

Glucobay tablets 50 mg: 1 tablet contains 50 mg acarbose 
Glucobay tablets 100 mg: 1 tablet contains 100 mg acarbose 

PHARMACEUTICAL FORM  

TABLETS 50 MG: White to
yellow-tinged round, convex tablets of 7 mm diameter and
10 mm 
radius of curvature. On one side the tablet code is “G” and
“50” and on the other side “Bayer 
cross”.  

TABLETS 100 MG : White to
yellow-tinged round, convex tablets of 9 mm diameter and 
15 mm r
adius of curvature. On one side the tablet code is
“G”,”score” and “100” and on the 
other side the “Bayer cross”. 

INDICATIONS  
Additional therapy in association with diet in patients with
diabetes mellitus. 

DOSAGE AND METHOD OF ADMINISTRATION  

RECOMMENDED  USUAL  DOSE  FOR  ADDITIONAL  THERAPY  IN  ASSOCIATION  WITH  DIET  IN  PATIENTS 
WITH DIABETES MELLITUS: 
_ _
The  dosage  must  be  adjusted  by  the  doctor  to  suit  each  patient,  because  efficacy  and 
tolerability vary from one individual to another. 

Unless otherwise prescribed, the recommended dosage is
as follows: 

Initially 3 x 1 tablet of  50 mg Glucobay/day or 3
x ½ tablet of 100 mg Glucobay/day 
up to 3 x 2 tablets of 50 mg Glucobay/day or 3 x 1
tablet of 100 mg Glucobay/day 

A further increase i

Summary of Product characteristics

Glucobay_PI_SG CCDS 19 July 2023
Page 1
Glucobay
®

-GLUCOSIDASE INHIBITOR
TABLETS
PRESCRIPTION USE ONLY
NAME OF THE MEDICINAL PRODUCT
Glucobay 50 mg tablets
Glucobay 100 mg tablets
QUALITATIVE AND QUANTITATIVE COMPOSITION
:
Glucobay tablets 50 mg: 1 tablet contains 50 mg acarbose
Glucobay tablets 100 mg: 1 tablet contains 100 mg acarbose
PHARMACEUTICAL FORM
TABLETS 50 MG: White to yellow-tinged round, convex tablets of 7 mm
diameter and 10 mm
radius of curvature. On one side the tablet code is “G” and
“50” and on the other side “Bayer
cross”.
TABLETS 100 MG : White to yellow-tinged round, convex tablets of 9 mm
diameter and
15 mm radius of curvature. On one side the tablet code is
“G”,”score” and “100” and on the
other side the “Bayer cross”.
INDICATIONS
Additional therapy in association with diet in patients with diabetes
mellitus.
DOSAGE AND METHOD OF ADMINISTRATION
RECOMMENDED USUAL DOSE FOR ADDITIONAL THERAPY IN ASSOCIATION WITH DIET
IN PATIENTS
WITH DIABETES MELLITUS:
The dosage must be adjusted by the doctor to suit each patient,
because efficacy and
tolerability vary from one individual to another.
Unless otherwise prescribed, the recommended dosage is as follows:
Initially 3 x 1 tablet of 50 mg Glucobay/day or 3 x ½ tablet of 100
mg Glucobay/day
up to 3 x 2 tablets of 50 mg Glucobay/day or 3 x 1 tablet of 100 mg
Glucobay/day
A further increase in dosage to 3 x 200 mg Glucobay/day may
occasionally be necessary.
The dose may be increased after 4 - 8 weeks, and if patients show an
inadequate clinical
response in the later course of the treatment. If distressing
complaints develop in spite of
strict adherence to the diet, the dose should not be increased
further, and if necessary
should be somewhat reduced. The average dose is 300 mg Glucobay/day
(corresponding to
3 x 2 tablets of Glucobay tablets 50 mg/day, or 3 x 1 tablet Glucobay
tablets 100 mg/day).
METHOD OF ADMINISTRATION:
Glucobay_PI_SG CCDS 19 July 2023
Page 2
Glucobay tablets are effective only if swallowed whole wit